trimethylamine has been researched along with Disbacteriosis in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Gut dysbiosis increases with aging, and it has been associated with the impairment of gut barrier function leading to the leakage of harmful metabolites such as trimethylamine (TMA)." | 9.41 | The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. ( Al-Arawe, N; El Hage, R; Hinterseher, I, 2023) |
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 8.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| " Gut dysbiosis increases with aging, and it has been associated with the impairment of gut barrier function leading to the leakage of harmful metabolites such as trimethylamine (TMA)." | 5.41 | The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. ( Al-Arawe, N; El Hage, R; Hinterseher, I, 2023) |
| " To demonstrate the potential for integrating big data into a functional microbiology workflow, we review literature on trimethylamine (TMA), a microbiota-generated metabolite linked to atherosclerosis development." | 4.91 | Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine. ( Falony, G; Raes, J; Vieira-Silva, S, 2015) |
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 4.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Choline is a water-soluble nutrient essential for human life." | 2.66 | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. ( Allison, J; Arboleya, S; Arias, JL; Arias, N; Gueimonde, M; Higarza, SG; Kaliszewska, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| El Hage, R | 1 |
| Al-Arawe, N | 1 |
| Hinterseher, I | 1 |
| Craven, H | 1 |
| Erlandsson, H | 1 |
| McGuinness, D | 1 |
| McGuinness, DH | 1 |
| Mafra, D | 1 |
| Ijaz, UZ | 1 |
| Bergman, P | 1 |
| Shiels, PG | 1 |
| Stenvinkel, P | 1 |
| Mogilnicka, I | 1 |
| Bogucki, P | 1 |
| Ufnal, M | 1 |
| Arias, N | 1 |
| Arboleya, S | 1 |
| Allison, J | 1 |
| Kaliszewska, A | 1 |
| Higarza, SG | 1 |
| Gueimonde, M | 1 |
| Arias, JL | 1 |
| Li, X | 1 |
| Su, C | 1 |
| Jiang, Z | 1 |
| Yang, Y | 1 |
| Zhang, Y | 1 |
| Yang, M | 1 |
| Zhang, X | 1 |
| Du, Y | 1 |
| Zhang, J | 1 |
| Wang, L | 1 |
| Jiang, J | 1 |
| Hong, B | 1 |
| Shen, TD | 1 |
| Chu, H | 1 |
| Duan, Y | 1 |
| Yang, L | 1 |
| Schnabl, B | 1 |
| Srinivasa, S | 1 |
| Fitch, KV | 1 |
| Lo, J | 1 |
| Kadar, H | 1 |
| Knight, R | 1 |
| Wong, K | 1 |
| Abbara, S | 1 |
| Gauguier, D | 1 |
| Capeau, J | 1 |
| Boccara, F | 1 |
| Grinspoon, SK | 1 |
| Falony, G | 1 |
| Vieira-Silva, S | 1 |
| Raes, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Alterations of Gut Microbiota and Metabolites in Asian Patients With Alcohol-associated Liver Disease[NCT05448144] | 200 participants (Anticipated) | Observational | 2022-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for trimethylamine and Disbacteriosis
| Article | Year |
|---|---|
The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
Topics: Aged; Aging; Animals; Atherosclerosis; Dysbiosis; Gastrointestinal Microbiome; Humans; Methylamines | 2023 |
Microbiota and Malodor-Etiology and Management.
Topics: Animals; Bacteria; Body Fluids; Dysbiosis; Gastrointestinal Microbiome; Halitosis; Host-Pathogen Int | 2020 |
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Choline; Diet; Dysbiosis; Gastrointestina | 2020 |
Diet and Gut Microbiota in Health and Disease.
Topics: Animals; Bacteria; Choline; Diet; Dietary Carbohydrates; Dysbiosis; Fecal Microbiota Transplantation | 2017 |
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease.
Topics: Bile Acids and Salts; Disease Progression; Dysbiosis; Ethanol; Fatty Acids, Volatile; Gastrointestin | 2019 |
Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine.
Topics: Animals; Atherosclerosis; Dysbiosis; Gastrointestinal Microbiome; Humans; Metagenomics; Methylamines | 2015 |
3 other studies available for trimethylamine and Disbacteriosis
| Article | Year |
|---|---|
A normative microbiome is not restored following kidney transplantation.
Topics: Dysbiosis; Gastrointestinal Microbiome; Humans; Kidney Transplantation; Microbiota; Renal Insufficie | 2023 |
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Topics: Animals; Atherosclerosis; Berberine; Choline; Diet; Disease Models, Animal; Disease Susceptibility; | 2021 |
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
Topics: Choline; Coronary Artery Disease; Dysbiosis; Female; HIV Infections; Humans; Intestinal Diseases; Ma | 2015 |